Distributive policy

Weekly State Policy Update 01/07/2022

This week’s update highlights legislative developments in California, Massachusetts, Pennsylvania and Washington, DC.

California

More than 750 Cal NORML supporters have written letters to their Assembly members in support of AB 2188, which prohibits employers from denying workers jobs or firing them based on a positive drug test. inactive metabolites of THC. These metabolites can be detected for days or weeks after use and have no correlation with work impairment.

If passed, California would be the seventh state to offer job protections to recreational users. The others are Nevada, New York, New Jersey, Connecticut, Montana and Rhode Island.

Update: The bill passed the Assembly and recently went to the Senate Labor Committee with a 4-1 vote. It now heads to supply. The California legislature will be on recess in July and back in August.

Send a message to your legislator today.

To note : AB 195 (Budget Committee) is an omnibus budget bill that included significant changes to cannabis taxes, including zeroing the cultivation tax indefinitely and moving the excise tax collection from distribution to retail, pushing back an automatic tax increase that would have taken effect in 2024, strengthening enforcement against unlicensed operators and providing further relief to social equity operators.

Update: AB 195 passed the Legislative Assembly with bipartisan support and now goes to the Governor, who is expected to sign it. AB 195 will take effect immediately after it is signed by the Governor, providing the legal cannabis industry with much-needed temporary tax relief, beginning July 1, 2022.

Massachusetts

Senate Bill 2823 outlines social equity provisions for the state’s cannabis industry as well as expectations regarding the creation of new businesses. If passed, the bill would require that a portion of the retail profits of social equity marijuana companies be reinvested in the community the company serves. It also requires host communities to encourage local people who have been disproportionately harmed by marijuana prohibition and enforcement to participate in the industry.

Update: Different versions of SB 2823 passed the House (153 to 2) and the Senate (39 to 0). The bill now heads to the conference committee so lammakers can agree on final language before it heads to the governor’s office.

Send a message to your Governor to support this effort.

Pennsylvania

Under current Pennsylvania law, a person is guilty of impaired driving if they drive with any amount of a Schedule I controlled substance or its metabolite under the controlled substances in his blood.

Senator Bartolotta’s Senate Bill 167 would change this law and treat patients with medical cannabis the same as patients using a prescription drug by requiring proof of actual tampering as the basis of a driving conviction. with weakened faculties. This legislation is essential to ensure that patients are not charged with a DUI for the mere presence of non-psychoactive metabolites and without evidence of actual impairment.

Update: SB 167 unanimously passed the Senate Transportation Committee and heads to the full Senate for a full vote.

Send a message to your legislators to support this effort.

washington d.c.

B24-0109, which seeks to prohibit any employer from taking adverse action against an employee for cannabis use, participation in the district’s medical cannabis program, or failure of an employer-required drug test for public safety jobs. Security-sensitive jobs may include occupations where firearms licenses are a requirement to be on duty. A provision in the bill would allow employers to take action against employees only if signs of their cannabis use negatively impact their job performance.

Update: The DC Council voted unanimously on June 7 to enact the Cannabis Job Protection Act. Mayor Muriel Bowser had 10 days to sign or do nothing for the bill to become law. Since the mayor did not sign the act, it will automatically be forwarded to Congress. Congress has 30 days to take action from the date of transmission.

Read more.